The protective effect was seen across several BMI levels, including in people with moderate overweight, not just class I/II obesity
Mike Haney: So the clinical indication, as I understand it, for getting one of these drugs for the purpose of obesity is a BMI of 30, or a BMI of 27 with another condition like diabetes
It is recognized for its ability to regulate blood sugar and assist in long-term weight management
After 8 weeks, the treatment group showed a 20% increase in hydration levels, measured by corneometry, and improved epidermal and dermal thickness due to enhanced glycosaminoglycan synthesis (Krger et al., 2010)
Clin Chest Med 39(4):753764 Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, Dhama K (2014) Oxidative stress, prooxidants, and antioxidants: the interplay
STEP-4: continued weekly semaglutide vs placebo switch for weight maintenance